Advertisements



With Mylan"s Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis

With Mylan"s Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis.....»»

Category: topSource: seekingalphaJun 13th, 2018

Amgen"s Neulasta Has a New Competitor

Mylan's biosimilar receives FDA approval for commercialization in the USRelated Stocks: AMGN, MYL,.....»»

Category: blogSource: gurufocusJun 17th, 2018

Mylan shares zoom on key approval and $4.5 billion market opportunity

The company scored the first U.S. approval of a biosimilar Neulasta late Monday, a lucrative product that has brought in billions in sales......»»

Category: topSource: marketwatchJun 6th, 2018

Mylan (MYL) Gets FDA Approval for Biosimilar of Neulasta

Mylan (MYL) and partner Biocon get a significant boost with t.....»»

Category: smallbizSource: nytJun 5th, 2018

Mylan shares zoom 7% on key approval and $4.5 billion market opportunity

The company scored the first U.S. approval of a biosimilar Neulasta late Monday, a lucrative product that has brought in billions in sales......»»

Category: topSource: marketwatchJun 5th, 2018

Mylan Wins Big With FDA Approval

Mylan saw its shares make a handy gain early on Tuesday after the FDA announced a key approval for Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim)......»»

Category: blogSource: 247wallstJun 5th, 2018

Mylan to have only a "minor" delay to generic Advair approval, says BMO Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Neulasta biosimilar could "reignite" Mylan momentum, says Morgan Stanley

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2018

Jefferies thesis on Amgen unchanged after Mylan biosimilar approval

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2018

Benzinga"s Daily Biotech Pulse: Mylan"s Neulasta Biosimilar Approved, Portola"s CEO To Retire, Regenxbio To Join S&P SmallCap Index

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 4) read more.....»»

Category: blogSource: benzingaJun 5th, 2018

Amgen falls after Neulasta biosimilar approved by FDA, Mylan spikes higher

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Mylan And Coherus: How To Play The Upcoming Neulasta Biosimilar Race

Mylan And Coherus: How To Play The Upcoming Neulasta Biosimilar Race.....»»

Category: topSource: seekingalphaJun 3rd, 2018

Biocon 483 letter won"t delay approval of Mylan"s Neulasta, says Bernstein

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2018

REGENXBIO (RGNX) in Focus: Stock Moves 6.2% Higher

Zacks.....»»

Category: topSource: redinews14 hr. 16 min. ago

Avnet (AVT) in Focus: Stock Moves 6.3% Higher

Zacks.....»»

Category: topSource: redinewsJun 18th, 2018

Oil falls as focus moves to prospect of higher supply

OPEC meets in Vienna next week that could increase production......»»

Category: topSource: foxnewsJun 15th, 2018

Asia Markets: Asian markets largely shrug off Trump’s approval of tariffs on China

Asian stocks opened mixed Friday following wide declines the previous day. The improved start also came after a European Central Bank-fueled jump in Europe and muted moves in the U.S. following Wednesday’s selloff after the Fed’s interest-rate hike......»»

Category: topSource: marketwatchJun 14th, 2018

Mylan (MYL) to Get CRL Again for Generic Advair from FDA

Mylan (MYL) suffers another setback with its ANDA for Advair as the FDA refuses to approve the same, due to minor deficiencies. Shares of Myla.....»»

Category: smallbizSource: nytJun 14th, 2018

Technical Take: Mylan falls after FDA says generic Advair has minor deficiencies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Morgan Stanley says Mylan Advair news likely seen as positive for Innoviva

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Advair generic delay negative news for Mylan, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018